Clinical Trials Browser

INDUSTRY × Interventional × Leukoplakia, Oral × Clear all

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Erythroplasia, Leukoplakia, Oral

NCT00002026 2005-06-24

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Phase NA Completed

AIDS-Related Complex, Leukoplakia, Oral, HIV Infections, AIDS-Related Opportunistic Infections, Leukoplakia, Hairy, Epstein-Barr Virus Infections

NCT00002043 2005-06-24

Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)

Phase NA Completed

AIDS-Related Complex, Candidiasis, Oral, Leukoplakia, Oral, Pneumonia, Pneumocystis, HIV Infections, AIDS-Related Opportunistic Infections